Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

122 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 13
Ph III recruiting: 2
Growth YoY: —
Industry share: 32%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05353205	A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.	unknown	Phase 4	200	Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY	1	Apr 29, 2022	clinicaltrials
NCT04677439	Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure	unknown	Phase 4	200	Shenzhen Second People's HospitalOTHER	1	Mar 16, 2022	clinicaltrials